Abstract
Background Cardiac involvement of patients with systemic lupus erythematosus (SLE) is one of the main complications contributing to morbidity and mortality, however a significant portion of patients presents with subclinical disease. Non-invasive contrast-enhanced cardiovascular magnetic resonance (CMR) imaging is a well-established diagnostic tool to identify myocardial tissue alterations and morphological and functional changes. In this study, we aimed to assess cardiac abnormalities in SLE patients using LGE-CMR and, furthermore, the relation of serological inflammatory biomarkers to the cardiac LGE-CMR findings.
Highlights
Cardiac involvement of patients with systemic lupus erythematosus (SLE) is one of the main complications contributing to morbidity and mortality, a significant portion of patients presents with subclinical disease
We studied 27 SLE patients (24 females, 45 ± 13 years) and 30 healthy age-matched volunteers who served as a control group (27 females, 44 ± 11 years)
The presence of LGE was associated with CRP levels higher than 2 mg/l (p = 0,03), independent of the pattern of cardiac involvement (Table 1)
Summary
Cardiac involvement of patients with systemic lupus erythematosus (SLE) is one of the main complications contributing to morbidity and mortality, a significant portion of patients presents with subclinical disease. We aimed to assess cardiac abnormalities in SLE patients using LGE-CMR and, the relation of serological inflammatory biomarkers to the cardiac LGE-CMR findings
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.